Skip to main content
Edmond Teng, MD, Neurology, Stanford, CA

EdmondHuatungTengMD

Neurology Stanford, CA

"Assistant Professor, David Geffen School of Medicine at UCLA Clinical Physician of Neurology, David Geffen School of Medicine at UCLA Co-Director, Katherine and Benjamin Kagan Alzheimer's Disease Treatment Dev. Program"

Dr. Teng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Teng's full profile

Already have an account?

  • Office

    300 Pasteur Dr
    Stanford, CA 94305
    Phone+1 650-723-4000

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2002 - 2005
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 2001 - 2002
  • University of California San Diego School of Medicine
    University of California San Diego School of MedicineClass of 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2026
  • American Board of Psychiatry and Neurology Neurology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Prevalence of Amyloid‐Β Pathology in Distinct Variants of Primary Progressive Aphasia  
    Gil D Rabinovici, William Seeley, Edmond Teng, David J Irwin, David A Wolk, Annals of Neurology

Press Mentions

  • Associations of Regional Brain Structural Differences with Aging, Modifiable Risk Factors for Dementia, and Cognitive Performance
    Associations of Regional Brain Structural Differences with Aging, Modifiable Risk Factors for Dementia, and Cognitive PerformanceDecember 2nd, 2019
  • Association of Altered Liver Enzymes with AD, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
    Association of Altered Liver Enzymes with AD, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid BiomarkersJuly 31st, 2019

Professional Memberships